Business Segment
(Millions of yen)
| 2020/3 | 2021/3 | 2022/3 | 2023/3 | 2024/3 | |
|---|---|---|---|---|---|
| New ethical drugs, etc. (Japan) | 77,535 | 69,735 | 69,725 | 74,770 | 82,581 |
| New ethical drugs (Overseas) | 1,490 | 996 | 1,033 | 308 | 386 |
| Generic drugs | 30,957 | 32,172 | 34,775 | 38,190 | 36,564 |
| Net sales | 109,983 | 102,904 | 105,534 | 113,270 | 119,532 |
“Accounting Standards for Revenue Recognition” (ASBJ Statement No.29, Mar 31, 2020) etc. have been applied from the beginning of March 2022.
Main Products
Beova
- Therapeutic agent for overactive bladder
- Beova Tablets 50mg
Lasvic
- New Quinolone synthetic antibacterial agent
- Lasvic Tablets 75mg
- Lasvic Intravenous Drip Infusion Kit 150mg
Lyfnua
- Cough treatment
- Lyfnua tablets 45mg
Desalex
- Antiallergic Agent
- Desalex Tablets 5mg
Flutiform
- Combination drug for asthma treatment
- Flutiform 50 Aerosol - 56 inhalations / 120 inhalations
- Flutiform 125 Aerosol - 56 inhalations / 120 inhalations
Pentasa
- Ulcerative Colitis / Crohn's Disease Remedy
- PENTASA Tablets 250mg
- PENTASA Tablets 500mg
- PENTASA Granules 94%
- Ulcerative Colitis Remedy
- PENTASA Enema 1g
- PENTASA Suppositories 1g
Kipres
- Leukotriene receptor antagonist
Anti-Bronchial asthma and allergic rhinitis drug - KIPRES Tablets 5mg
- KIPRES Tablets 10mg
- KIPRES OD Tablets 10mg
- Leukotriene receptor antagonist
Anti-Bronchial asthma drug - KIPRES Fine Granules 4mg
- KIPRES Chewable Tablets 5mg
Mucodyne
- Mucoregulating drug
- MUCODYNE Tablets 250mg
- MUCODYNE Tablets 500mg
- MUCODYNE Syrup 5%
- MUCODYNE DS 50%
Nasonex
- Allergic Rhinitis Therapeutic agent
- NASONEX Nasal 50μg 56sprays
- NASONEX Nasal 50μg 112sprays
Uritos
- Therapeutic agent for overactive bladder
- URITOS Tablets 0.1mg
- URITOS OD Tablets 0.1mg
Montelukast “KM”
- Treatment for Bronchial asthma, allergic rhinitis
- MONTELUKAST Tablets 5mg “KM”
- MONTELUKAST Tablets 10mg “KM”
Mometasone “KYORIN”
- Allergic Rhinitis Therapeutic Agent
- MOMETASONE NASAL 50μg “KYORIN”56sprays
- MOMETASONE NASAL 50μg “KYORIN”112sprays
Imidafenacin “KYORIN”
- Therapeutic agent for overactive bladder
- IMIDAFENACIN Tablets 0.1mg “KYORIN”
- IMIDAFENACIN OD Tablets 0.1mg “KYORIN”
(Billions of yen)
| 2020/3 | 2021/3 | 2022/3 | 2023/3 | 2024/3 | |
|---|---|---|---|---|---|
| Beova | 4.3 | 7.3 | 8.6 | 12.9 | 18.1 |
| Lasvic | 1.1 | 0.9 | 1.8 | 2.5 | 4.9 |
| Lyfnua | - | - | - | 0.2 | 0.8 |
| Desalex | 2.6 | 5.7 | 7.1 | 8.5 | 8.9 |
| Flutiform | 14.6 | 13.3 | 12.6 | 12.0 | 12.9 |
| Pentasa | 13.3 | 12.8 | 14.0 | 12.8 | 12.3 |
| Kipres | 11.8 | 8.3 | 8.4 | 6.6 | 7.0 |
| Mucodyne | 5.8 | 3.3 | 3.5 | 3.5 | 4.2 |
| Nasonex | 6.0 | 2.8 | 2.4 | 2.5 | 2.0 |
| Uritos | 5.8 | 2.3 | 1.3 | 0.7 | 0.5 |
| Montelukast “KM” | 11.5 | 10.8 | 12.2 | 13.3 | 12.3 |
| Mometasone “KYORIN” | 2.8 | 3.8 | 3.6 | 4.7 | 4.5 |
| Imidafenacin “KYORIN” | - | 0.7 | 0.8 | 0.7 | 0.6 |